...
首页> 外文期刊>Peptides: An International Journal >Neuropeptide-Y in the paraventricular nucleus increases ethanol self-administration.
【24h】

Neuropeptide-Y in the paraventricular nucleus increases ethanol self-administration.

机译:脑室旁核中的神经肽-Y可增加乙醇的自我管理。

获取原文
获取原文并翻译 | 示例
           

摘要

The paraventricular nucleus (PVN) of the hypothalamus is known to modulate feeding, obesity, and ethanol intake. Neuropeptide-Y (NPY), which is released endogenously by neurons projecting from the arcuate nucleus to the PVN, is one of the most potent stimulants of feeding behavior known. The role of NPY in the PVN on ethanol self-administration is unknown. To address this issue, rats were trained to self-administer ethanol via a sucrose fading procedure and injector guide cannulae aimed at the PVN were surgically implanted. Microinjections of NPY and NPY antagonists in the PVN were conducted prior to ethanol self-administration sessions. All doses of NPY significantly increased ethanol self-administration and preference, and decreased water intake. The NPY antagonist D-NPY partially reduced ethanol self-administration and completely blocked the effects of an intermediate dose of NPY (10 fmol) on ethanol intake, preference, and water intake. The competitive non-peptide Y1 receptor antagonist BIBP 3226 did not significantly alter ethanol self-administration or water intake when administered alone in the PVN but it completely blocked the effect of NPY (10 fmol) on ethanol intake. NPY infused in the PVN had no effect on ethanol self-administration when tested in rats that did not have a long history of ethanol self-administration. The doses of NPY tested produced no effect on food intake or body weight measured during the 24-h period after infusion in either ethanol-experienced or ethanol-inexperienced rats. These results indicate that elevation of NPY levels in the PVN potently increases ethanol self-administration and that this effect is mediated through NPY Y1 receptors.
机译:下丘脑室旁核(PVN)可以调节摄食,肥胖和乙醇摄入。神经肽-Y(NPY)是由弓形核投射到PVN的神经元内源性释放的,是已知最有效的进食行为刺激剂之一。 NPY在PVN中对乙醇自我给药的作用尚不清楚。为了解决这个问题,对大鼠进行了训练,使其通过蔗糖褪色程序自我施用乙醇,并通过外科手术植入了针对PVN的注射器引导套管。在乙醇自我给药之前,先在PVN中显微注射NPY和NPY拮抗剂。所有剂量的NPY均可显着增加乙醇的自我管理和偏好,并减少饮水量。 NPY拮抗剂D-NPY部分减少了乙醇的自我给药,并完全阻止了中等剂量NPY(10 fmol)对乙醇摄入,偏爱和水摄入的影响。竞争性非肽Y1受体拮抗剂BIBP 3226在PVN中单独给药时,不会显着改变乙醇的自我给药或饮水量,但完全阻断了NPY(10 fmol)对乙醇摄入的影响。当在没有悠久的乙醇自我管理史的大鼠中进行测试时,在PVN中注入的NPY对乙醇自我管理没有影响。在有乙醇经验的或无乙醇经验的大鼠中,输注后24小时内测试的NPY剂量对食物摄入或体重没有影响。这些结果表明,PVN中NPY水平的升高有效地增加了乙醇的自我给药,并且这种作用是通过NPY Y1受体介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号